Experts weigh pros and cons of COVID-19 vaccine booster shots


An FDA advisory panel is scheduled to satisfy on Friday to debate and vote on Pfizer’s COVID-19 vaccine booster shots.

In August, President Biden introduced his plan to get booster shots into arms as early as September 20 to struggle again towards the coronavirus.

But getting the FDA to approve a 3rd shot earlier than that date is an uphill battle. 

Pfizer stated research present individuals who obtained a booster shot six to eight months after their second dose of the Pfizer vaccine tripled their antibodies — growing safety towards gentle an infection and the contagious Delta variant.

Experts like Dr. Ashish Jha, dean of the Brown University School of Public Health, say they consider that based mostly off publicly accessible knowledge, it does seem {that a} third shot is protected and efficient.

“I think people who are vulnerable, people who are older, people with chronic diseases, immunocompromised, they would benefit from a third shot. I think it is necessary for that group. For young and healthy people, I am far less convinced that we need that third shot,” Jha stated on “CBS Mornings”

Scientists on the World Health Organization got here out towards the United States’ booster plans and stated that international locations just like the U.S. ought to chorus from issuing booster shots till vaccine provides are excessive sufficient in different international locations which are struggling to vaccinate their populations.

Supporters of distributing booster shots have pointed to Israel, which already permitted a 3rd dose of the Pfizer vaccine. A examine from Israel discovered that the shot elevated safety towards extreme sickness in individuals 60 and older.

But FDA reviewers this week warned towards counting on research from different international locations as a result of the company hadn’t independently verified the info or their conclusions.

In an try to clear up confusion, White House press secretary Jen Psaki stated Thursday that the Biden administration is listening to prime well being officers who help handing out COVID boosters. Psaki stated they are going to be ready to distribute when the FDA approves the shot.

Jha added navigating the general public messaging for the necessity for shot quantity three is “tricky” for the Biden administration.

“It’s a tricky thing for the Biden administration because on one hand they obviously want to, we all want to get unvaccinated people vaccinated because that is by far the most important thing we can be doing,” Jha stated. “But there are older, vulnerable people, people in nursing homes and elsewhere who probably need that third shot. And they’ve got to prepare for that population, as well. So it is a tricky message, but we’ve got to get both of those messages out there.”